Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_assertion type Assertion NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_head.
- NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_assertion description "[The finding of Bcl-2 overexpression in poorly differentiated NECs, particularly small cell NEC, suggests that Bcl-2 antagonists/inhibitors may be a viable treatment option for these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_provenance.
- NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_assertion evidence source_evidence_literature NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_provenance.
- NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_assertion SIO_000772 22251937 NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_provenance.
- NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_assertion wasDerivedFrom befree-2016 NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_provenance.
- NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_assertion wasGeneratedBy ECO_0000203 NP953880.RAsPmwGpvbRbMxNDzOs90Umvs9oTUsKU5YatVpVWxQUQs130_provenance.